Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Elucidating the susceptibility to breast cancer: an in-depth proteomic and transcriptomic investigation into novel potential plasma protein biomarkers

Frontiers in Molecular Biosciences(2024)10.3389/fmolb.2023.1340917Source: DataRank Database

Elucidating the susceptibility to breast cancer: an in-depth proteomic and transcriptomic investigation into novel potential plasma protein biomarkers is a research paper published in Frontiers in Molecular Biosciences (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (11)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Kexin Yi ORCID,Baoyue Chen,Bailin Zhang ORCID,Gao Jidong,Yang Wang ORCID

Live enrichment

PubMed:38304232 PMC:PMC10833003

NCI NIH HHS

Grant: U19 CA148065

European Commission

Grant: 223175

Collaborative Oncological Gene-environment Study

European Commission

Grant: 633784

Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes

National Institutes of Health

Grant: 5U19CA148065-04

Discovery Expansion and Replication

European Commission

Grant: 634935

Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)

Canadian Institutes of Health Research

Grant: unidentified

unidentified

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fmolb.2023.1340917/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fmolb.2023.1340917/full

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10833003/pdf/fmolb-10-1340917.pdf

repositoryhttps://doaj.org/article/3ad13e70d2f74f2b8745fad863998f7b

Europe_PMChttps://europepmc.org/articles/PMC10833003

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Breast cancerMendelian RandomizationPlasma ProteinsTranscriptome-wide Association StudyProteome-wide Association StudyQH301-705.5Molecular BiosciencesBiology (General)

Sustainable Development Goals

SDG 3: 3. Good health

Elucidating the susceptibility to breast cancer: an in-depth proteomic and transcriptomic investigation into novel potential plasma protein biomarkers

FAIR Checklist

Authors (5)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)